The Effectiveness of Engagement-based Personalization of a Digital Mental Health Intervention
1 other identifier
interventional
200
1 country
1
Brief Summary
This study will investigate the effectiveness of an engagement-based personalized 2-week mobile wellbeing intervention, vs the effectiveness of a non-personalized 2-week mobile wellbeing intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2022
CompletedFirst Posted
Study publicly available on registry
March 29, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedJune 8, 2023
June 1, 2023
8 months
March 3, 2022
June 7, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Change from baseline in wellbeing, measured with the Mental Health Continuum Short Form, at 3 weeks.
Wellbeing will be measured in an online survey, using the Mental Health Continuum Short Form. This validated scale consists of 14 items. The scale's total scores range from 14 to 84, with higher scores indicating higher wellbeing and thus better outcomes.
baseline, 3 weeks
Change from baseline in depressive symptoms, measured with the Patient Health Questionnaire-9, at 3 weeks.
Depressive symptoms will be measured in an online survey, using the Patient Health Questionnaire-9. This validated scale consists of 9 items. The scale's total scores range from 0 to 27, with higher scores indicating higher depressive symptoms and thus worse outcomes.
baseline, 3 weeks
Change from baseline in anxiety symptoms, measured with the Generalized Anxiety Disorder 7-item scale, at 3 weeks.
Depressive symptoms will be measured in an online survey, using the Generalized Anxiety Disorder 7-item scale. This validated scale consists of 6 items. The scale's total scores range from 0 to 21, with higher scores indicating higher anxiety symptoms and thus worse outcomes.
baseline, 3 weeks
Secondary Outcomes (7)
Adherence
after 3 weeks
Engagement, measured with the TWente Engagement with Ehealth Technologies Scale.
after 1 day
Engagement, measured with the TWente Engagement with Ehealth Technologies Scale.
after 7 days
Engagement, measured with the TWente Engagement with Ehealth Technologies Scale.
after 3 weeks
Change from baseline in wellbeing, measured with the Mental Health Continuum Short Form, at 8 weeks.
baseline, 8 weeks
- +2 more secondary outcomes
Study Arms (2)
Personalized
EXPERIMENTALParticipants in the personalized arm will receive the optimal combination of content, feedback and design, based on their baseline engagement scores.
non-personalized
ACTIVE COMPARATORParticipants in the non-personalized arm will receive a randomly selected version of the 27 possible interventions, regardless of their baseline engagement scores.
Interventions
For the study, 27 versions of a 2-week mobile wellbeing intervention are created. These versions vary on content (Cognitive Behavioral Therapy, meaning, positive psychology), feedback (text, text with avatar, pre-recorded video) and design (non-gamified, competitively gamified, storyline gamified). At baseline, participants preview all variations and indicate their expected engagement. Participants in the personalized condition will receive the optimal combination of content, feedback and design, based on their baseline engagement scores. Each version of the intervention consists of a module per day. Each module contains psychoeducation and exercises based on content of the version. Moreover, each module contains pre-specified general feedback and supportive messages.
For the study, 27 versions of a 2-week mobile wellbeing intervention are created. These versions vary on content (Cognitive Behavioral Therapy, meaning, positive psychology), feedback (text, text with avatar, pre-recorded video) and design (non-gamified, competitively gamified, storyline gamified). At baseline, participants preview all variations and indicate their expected engagement. Participants in the non-personalized condition will receive a random version of the intervention. Each version of the intervention consists of a module per day. Each module contains psychoeducation and exercises based on content of the version. Moreover, each module contains pre-specified general feedback and supportive messages.
Eligibility Criteria
You may qualify if:
- at least mild depressive or anxiety complaints; \>4 Generalized Anxiety Disorder 7-item scale OR Patient Health Questionnaire 9-item scale
- access to smartphone with internet
- adequate English literacy
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Twente
Enschede, Netherlands
Study Officials
- PRINCIPAL INVESTIGATOR
Saskia M Kelders, PhD
University of Twente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants will not be informed about their randomized condition (personalized or non-personalized), but it is likely that they will infer it from the intervention that they receive.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 3, 2022
First Posted
March 29, 2022
Study Start
April 1, 2022
Primary Completion
December 1, 2022
Study Completion
February 1, 2023
Last Updated
June 8, 2023
Record last verified: 2023-06